Compounded semaglutide vs brand name Wegovy: what is the real difference?

Short answer

• The active drug (semaglutide) can be the same molecule in both, but Wegovy is an FDA‑approved, factory‑made, quality‑tested product with clinical trial data for weight loss; compounded semaglutide is made by a pharmacy to a prescription and is not FDA‑approved, so its source, potency, sterility and stability can vary. That difference matters for safety, effectiveness, and legal/insurance issues.

Key differences (concise)

1. FDA approval and evidence

• Wegovy (Novo Nordisk) is FDA‑approved for chronic weight management and supported by large randomized trials that define safe titration schedules, side‑effect rates and long‑term outcomes.
• Compounded semaglutide is not FDA‑approved. Compounded products don’t have the same completed clinical testing for safety, efficacy, or manufacturing consistency.

1. Quality control, purity and sterility

• Wegovy is manufactured under strict GMP, with validated assays for potency, purity and sterility.
• Compounded versions depend on the pharmacy’s practices. There can be variability in potency, unknown impurities, and a higher risk of contamination unless the pharmacy follows high standards and testing.

1. Formulation, delivery device and stability

• Wegovy comes as prefilled pens with specified concentrations and labeled dosing steps (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg weekly).
• Compounded semaglutide may be supplied in syringes, vials, or mixed doses; compounding may affect stability and how accurately a patient can dose. Pens reduce dosing errors and contamination risk.

1. Sourcing of active ingredient

• Wegovy’s API and supply chain are controlled and regulated.
• Compounding pharmacies sometimes buy bulk API from third parties (often overseas). If the API supplier is not reputable, the product may contain impurities or wrong potency.

1. Cost, insurance and access

• Wegovy is expensive and not always covered by insurance; that is the main driver for people choosing compounded versions because they can be cheaper.
• Compounded semaglutide is usually paid out of pocket and not FDA‑covered; it may be less expensive but comes with the quality tradeoffs above.

1. Legal/regulatory points

• Pharmacies can legally compound for an individual patient with a prescription, but the FDA has warned against compounding copies of approved drugs when commercial products are available for reasons of safety and supply chain concerns.
• Some clinics or online vendors selling “compounded semaglutide” operate in gray areas — be cautious.

1. Safety and monitoring

• Wegovy’s label gives specific titration schedules and warnings (pancreatitis, thyroid C‑cell tumors in rodents, gallbladder disease, etc.). Your prescriber and pharmacist follow established guidelines.
• With compounded products, dosing errors or inadequate instructions are more likely. Adverse effects can be the same or worse if potency/sterility are off.

If you’re considering compounded semaglutide — what to ask and look for

• Is the pharmacy accredited (PCAB) and do they follow USP <797>/<800> sterile compounding standards?
• Can they provide a Certificate of Analysis (COA) for the API (showing identity and potency) and sterility testing results?
• How is the product supplied (prefilled pen vs vial/syringe)? What is the exact concentration and dosing instructions?
• Who is responsible for patient counseling and monitoring?
• Why is the prescriber favoring compounding over Wegovy? Was an FDA‑approved option discussed?
• Beware of internet sellers without a physical, accredited pharmacy.

Alternatives to consider

• If cost or access to Wegovy is the problem, discuss options with your clinician: Novo Nordisk sometimes has patient savings programs; Ozempic (semaglutide for diabetes) is a different Wegovy regimen that some clinicians use off‑label for weight loss; oral semaglutide (Rybelsus) is another semaglutide formulation (different dosing/efficacy). Newer drugs (e.g., tirzepatide brands Mounjaro or Zepbound) are other prescriptions for weight loss to discuss.

Bottom line Wegovy gives you an FDA‑approved, consistently manufactured, labeled product with clinical trial evidence for weight loss. Compounded semaglutide can be cheaper but carries risks around potency, sterility, supply‑chain transparency and legal/insurance coverage. If you’re thinking about compounded semaglutide for cost or access, talk with your prescriber and use only an accredited compounding pharmacy that can document API source, COAs and sterile compounding practices.